+Vote!
PR News Wire (Free subscription) | 3 hours ago
EMERYVILLE, Calif., Nov. 11 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific Time). Interested parties may access a live webcast of the presentation on our website at:
4Vote!
MarketIntelligenceCenter.com (Free subscription) | 11 hours ago
Lazard (NYSE: LAZ) closed yesterday at $40.13. So far the stock has hit a 52-week low of $19.17 and 52-week high of $44.62. Lazard stock has been showing support around 38.58 and resistance in the 41.08 range. Technical indicators for the stock are Bullish and S&P gives LAZ a positive 4 STAR (out of 5) buy rating. LAZ appears on the Investors Observer Hedged Dividend Income list....
5Vote!
Business Wire (Free subscription) | 11 hours ago
ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the Company will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18th at 3:15 p.m. Eastern time (12:15 p.m. Pacific time) at the St. Regis in New York. The Lazard Healthcare Conference provides the opportunity for participating companies...
+Vote!
Business Wire (Free subscription) | 3 hours ago
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq:GILD) today announced that its corporate presentation will be webcast from the Lazard Capital Markets 6th Annual Healthcare Conference in New York. Gregg H. Alton, Gilead’s Executive Vice President, Corporate and Medical Affairs, will provide an overview of the company on Tuesday, November 17 at 2:10 p.m. Eastern Time....
4Vote!
Business Wire (Free subscription) | 3 hours ago
LIMERICK, Pa.--(BUSINESS WIRE)--Jeffrey P. Black, chairman and chief executive officer, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City, New York, on Tuesday, November 17, 2009 at 4:10 p.m. (ET). An audio webcast including the slide presentation will be available on the investor portion...
+Vote!
Business Wire (Free subscription) | 3 hours ago
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference at 3:45 p.m. EST on November 18, 2009, in New York City. Dan Passeri, Curis’ President...
+Vote!
Business Wire (Free subscription) | 4 hours ago
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading vertically integrated clinical lab, life sciences and therapeutic biotechnology company, announced today that Barry Weiner, President, and David Goldberg, Vice President, Corporate Development, will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009 at 3:40 PM at The St....
4Vote!
Business Wire (Free subscription) | 7 hours ago
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (NASDAQ: BRKR) announced today that it will present at the Lazard Capital Markets 6th Annual Healthcare Conference on Tuesday, November 17, 2009, at 10:55 AM Eastern Standard Time in New York City. William Knight, Chief Financial Officer, will speak on behalf of the Company. A live audio webcast of this presentation will also be available...
5Vote!
Market Wire (Free subscription) | 7 hours ago
MADISON HEIGHTS, MI (MARKET WIRE) InfuSystem Holdings, Inc. (OTCBB: INHI); (OTCBB: INHIW); (OTCBB: INHIU), the leading provider of ambulatory infusion pumps and associated clinical services, today announced that it will participate in Lazard Capital Markets 6th Annual Healthcare Conference, to be held November 17-18, 2009, in New York. Sean McDevitt, Chairman and Chief Executive Officer of InfuSystem,...
4Vote!
Business Wire (Free subscription) | 8 hours ago
FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (NYSE: CYH) today announced that management will participate in the Lazard Capital Markets 6th Annual Healthcare Conference to be held November 17-18, 2009, at the St. Regis Hotel in New York City. The investor presentation will begin at 10:30 a.m. Central time, 11:30 a.m. Eastern time, on Wednesday, November 18, 2009, and will...
4Vote!
Business Wire (Free subscription) | 9 hours ago
CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that Dr. Leonard Bell, Chief Executive Officer of Alexion Pharmaceuticals, will present at Lazard Capital Markets 6th Annual Healthcare Conference in New York City at 10:00 a.m. ET on Wednesday, November 18, 2009. An audio webcast of Dr. Bell’s remarks will be available live. You can access the...
+Vote!
Business Wire (Free subscription) | 10 hours ago
WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics™, today announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the Lazard Capital Markets 6th Annual Healthcare Conference at the St. Regis Hotel in New York City...
4Vote!
Business Wire (Free subscription) | 11 hours ago
LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the Lazard Capital Markets 6th Annual Healthcare Conference on Wednesday, November 18 at 10:00 a.m. (ET) at the St. Regis...
4Vote!
Business Wire (Free subscription) | 11 hours ago
SAN CARLOS, Calif.--(BUSINESS WIRE)--Alvine Pharmaceuticals, Inc., a privately held biopharmaceutical company focused on developing and commercializing therapeutics for autoimmune/gastrointestinal diseases, today announced President and Chief Executive Officer Abhay Joshi will present at the Lazard Capital Markets Sixth Annual Healthcare Conference at 11:30 a.m. ET on Wednesday, November 18....
4Vote!
Business Wire (Free subscription) | 12 hours ago
MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV) will present at the Lazard Capital Markets 6th Annual Healthcare Conference in New York on Wednesday, November 18, 2009. Coleman Lannum, Vice President, Investor Relations, will represent the Company in a session scheduled at 11:30 a.m. ET. A live audio webcast of the presentation can be accessed at Covidien’s Investor Relations website:...
